June 25, 2009- Medicsight PLC, a computer-aided detection (CAD) and image analysis software developer, signed a non-exclusive, software license and distribution agreement with Alma IT Systems (“Alma”), a leading developer of advanced digital medical imaging tools, across Europe and South America.

This will give Medicsight access to Alma’s large and established installed base of radiology customers in key markets. As part of this agreement Medicsight’s ColonCAD API 4.0 software will be integrated into Alma’s latest Colon viewer, a 3D visualization workstation which interprets computed tomographic colonography (CTC) image data. Alma is one of Spain’s market leaders in medical imaging technology. It is anticipated that the new product will be offered to both clinicians and PACS customers via the ALMA 3D workstation and server-based client platforms.

The prototype Alma 3D Colon viewer is available for demonstration on the Medicsight booth (number 13) at the 20th Annual European Society of Gastrointestinal and Abdominal Radiology (ESGAR 2009) taking place this week in Valencia.

For more information: www.medicsight.com


Additional Content

News | ACR

February 6, 2024 — An update to the CT Colonography Reporting and Data System (C-RADS) has been published Jan. 30 in the ...

Time February 06, 2024
arrow
News | Colonoscopy Systems

A team of Johns Hopkins data researchers is studying the economic and safety implications associated with the devices used to perform colonoscopies as a disposable version inches closer to widespread availability.

Time August 26, 2019
arrow
News | Colonoscopy Systems

A new study finds that trends in colonoscopy rates did not fully align with the increase in colorectal cancer (CRC) in younger adults, adding to evidence that the rise in early onset CRC is not solely a result of more detection. The study is published early online in the Journal of Medical Screening.

Time August 06, 2019
arrow
News | Colonoscopy Systems

Check-Cap Ltd. has initiated its U.S. pilot study of the C-Scan system for prevention of colorectal cancer through detection of precancerous polyps, following Institutional Review Board (IRB) approval and full Investigational Device Exemption (IDE) application approval by the U.S. Food and Drug Administration (FDA). The first patients have ingested C-Scan, a preparation-free capsule, at the New York University School of Medicine.

Time April 15, 2019
arrow
News | Colonoscopy Systems

https://www.congress.gov/bill/115th-congress/house-bill/1298?q=%7B%22se… cancer care advocacy groups and medical societies are calling on Congress to pass the CT Colonography Screening for Colorectal Cancer Act (S.3465/HR 1298). The bipartisan bill introduced in the U.S. Senate September 19 would provide Medicare coverage for screening computed tomography colonography (CTC), commonly known as virtual colonoscopy.

Time September 27, 2018
arrow
Subscribe Now